Ortega C - Search Results

1

Customizably designed multibodies neutralize SARS-CoV-2 in a variant-insensitive manner.

Abreu C, Ortega C, Olivero-Deibe N, Carrión F, Gaete-Argel A, Valiente-Echeverría F, Soto-Rifo R, Milan Bonotto R, Marcello A, Pantano S. Abreu C, et al. Among authors: ortega c. Front Immunol. 2023 Aug 10;14:1226880. doi: 10.3389/fimmu.2023.1226880. eCollection 2023. Front Immunol. 2023. PMID: 37638023 Free PMC article.

2

CUTie2: The Attack of the Cyclic Nucleotide Sensor Clones.

Klein F, Sardi F, Machado MR, Ortega C, Comini MA, Pantano S. Klein F, et al. Among authors: ortega c. Front Mol Biosci. 2021 Mar 11;8:629773. doi: 10.3389/fmolb.2021.629773. eCollection 2021. Front Mol Biosci. 2021. PMID: 33778003 Free PMC article.

3

Multi-Compartment and Multi-Host Vector Suite for Recombinant Protein Expression and Purification.

Ortega C, Prieto D, Abreu C, Oppezzo P, Correa A. Ortega C, et al. Front Microbiol. 2018 Jun 27;9:1384. doi: 10.3389/fmicb.2018.01384. eCollection 2018. Front Microbiol. 2018. PMID: 29997597 Free PMC article.

4

Overview of High-Throughput Cloning Methods for the Post-genomic Era.

Ortega C, Abreu C, Oppezzo P, Correa A. Ortega C, et al. Methods Mol Biol. 2019;2025:3-32. doi: 10.1007/978-1-4939-9624-7_1. Methods Mol Biol. 2019. PMID: 31267446

5

Production, purification and characterization of a double-tagged TEV protease.

Rizza JD, Ortega C, Carrión F, Fló M, Correa A. Rizza JD, et al. Among authors: ortega c. Protein Expr Purif. 2022 Mar;191:106021. doi: 10.1016/j.pep.2021.106021. Epub 2021 Nov 16. Protein Expr Purif. 2022. PMID: 34798273

6

Generation of a vector suite for protein solubility screening.

Correa A, Ortega C, Obal G, Alzari P, Vincentelli R, Oppezzo P. Correa A, et al. Among authors: ortega c. Front Microbiol. 2014 Feb 25;5:67. doi: 10.3389/fmicb.2014.00067. eCollection 2014. Front Microbiol. 2014. PMID: 24616717 Free PMC article.

7

Overcoming the Solubility Problem in E. coli: Available Approaches for Recombinant Protein Production.

Ortega C, Oppezzo P, Correa A. Ortega C, et al. Methods Mol Biol. 2022;2406:35-64. doi: 10.1007/978-1-0716-1859-2_2. Methods Mol Biol. 2022. PMID: 35089549 Review.

8

Docetaxel in chitosan-based nanocapsules conjugated with an anti-Tn antigen mouse/human chimeric antibody as a promising targeting strategy of lung tumors.

Castro A, Berois N, Malanga A, Ortega C, Oppezzo P, Pristch O, Mombrú AW, Osinaga E, Pardo H. Castro A, et al. Among authors: ortega c. Int J Biol Macromol. 2021 Jul 1;182:806-814. doi: 10.1016/j.ijbiomac.2021.04.054. Epub 2021 Apr 12. Int J Biol Macromol. 2021. PMID: 33857513

9

[What patients with cancer think about the dehospitalization. A survey of Cipomo.].

Barni S, Aschele C, Blasi L, Giordano M, Ortega C, Pinotti G, Artioli F, Fioretto L, Daniele B, Aprile G, Silva RR, Montesarchio V. Barni S, et al. Among authors: ortega c. Recenti Prog Med. 2024 May;115(5):232-237. doi: 10.1701/4262.42402. Recenti Prog Med. 2024. PMID: 38708534 Italian.

10

An International Expert-Based Consensus on the Definition of a Clinical Near-Complete Response After Neoadjuvant (Chemo)radiotherapy for Rectal Cancer.

Custers PA, Beets GL, Bach SP, Blomqvist LK, Figueiredo N, Gollub MJ, Martling A, Melenhorst J, Ortega CD, Perez RO, Smith JJ, Lambregts DMJ, Beets-Tan RGH, Maas M. Custers PA, et al. Among authors: ortega cd. Dis Colon Rectum. 2024 Jun 1;67(6):782-795. doi: 10.1097/DCR.0000000000003209. Epub 2024 May 2. Dis Colon Rectum. 2024. PMID: 38701503

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

491 results

Search Page